查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1641742

全球藥物濫用檢測市場按產品/服務、樣本類型和最終用戶分類 - 機會分析和產業預測（2024-2033 年）

Drug Abuse Testing Market By Product and Service , By Sample type By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023 年全球藥物濫用檢測市場規模為 500 萬美元，預計到 2033 年將達到 880 萬美元，2024 年至 2033 年的複合年成長率為 6%。

藥物濫用檢測市場-IMG1

藥物濫用測試是指辨識人體內是否有非法藥物、處方藥或其代謝物的科學過程。這些測試是對尿液、血液、唾液、頭髮或汗水等生物檢體進行的，以確定個人是否使用了特定物質。藥物濫用測試是職場安全、臨床診斷、法律調查和康復計劃的重要工具。

全球藥物濫用障礙的驚人成長是藥物濫用測試市場的主要驅動力。聯合國毒品犯罪防制署（UNODC）的一份報告估計，到 2022 年，將有超過 2.84 億 15 至 64 歲的人至少使用過一次毒品，這凸顯了進行廣泛檢測的必要性。此外，人們越來越意識到藥物濫用（例如酒後駕駛和毒品犯罪）對公共安全的影響，這也推動了執法和交通監控計畫中定期進行藥物測試的需求。此外，全球藥品供應的增加也大大促進了市場的成長。例如，歐洲毒品和毒癮監測中心 (EMCDDA) 預測，到 2024 年，歐洲各種毒品的供應將比以往任何時候都要充足，其中大麻是最常用的非法毒品，其次是可卡因。 。此外，經濟高效且易於使用的家用藥物檢測套組的普及，也使個人和家庭對其的採用越來越廣泛，從而促進了市場的擴大。然而，液相層析法質譜等先進的藥物檢測技術價格昂貴。這可能會限制採用，尤其是在資源受限的醫療保健環境中。對社會評判和歧視的恐懼可能會阻止個人自願接受藥物測試，從而進一步影響測試項目的發展。相反，即時檢測設備、改進的免疫檢測和質譜技術等技術創新正在使藥物檢測更加準確、快速和易於實現。預計這些發展將為預測期內全球市場的擴張提供有利可圖的機會。

藥物濫用測試市場分為產品/服務、樣本類型、最終用戶和地區。根據產品/服務，市場細分為分析儀器、快速測試設備、消耗品和化驗服務。分析儀器又分為免疫檢測分析儀、層析法分析儀、呼氣分析儀等。快速檢測設備細分為尿液檢查設備及口腔液體檢測設備。消耗品部分進一步分為檢測試劑套件、樣本收集杯、校準器和控制器以及其他。依樣本類型，分為尿液、口腔液、呼吸、頭髮和其他樣本。根據最終用戶，市場分為職場/學校、刑事司法系統/執法部門、實驗室和醫院。按地區分析，涵蓋北美、歐洲、亞太地區、拉丁美洲、中東和非洲。

主要發現

按產品/服務分類，分析儀器在 2023 年佔據了市場佔有率。

根據樣本類型，預計尿液部分將在 2023 年達到最高成長。

根據最終用戶，職場和學校部門在 2023 年佔據最大佔有率。

根據地區，預計北美將在 2023 年佔據最大的市場佔有率，並且預計在預測期內將以高速成長。

本報告可提供客製化（請聯絡銷售人員以了解其他費用和時間表）

  • 監管指南
  • 根據客戶興趣加入公司簡介
  • 按國家或地區進行的附加分析：市場規模和預測
  • 平均售價分析/價格點分析
  • 交叉細分分析：市場規模與預測
  • 擴展公司簡介列表
  • 歷史市場資料
  • Excel 格式的主要企業詳細資料（包括位置、聯絡資訊、供應商/供應商網路等）

目錄

第 1 章 簡介

第 2 章執行摘要

第3章 市場狀況

  • 市場定義和範圍
  • 主要發現
    • 主要投資機會
    • 關鍵成功策略
  • 波特五力分析
  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會

4. 藥物濫用檢測市場（依產品和服務）

  • 市場概況
  • 分析設備
    • 免疫檢測分析儀
    • 層析法分析設備
    • 呼吸分析儀
  • 快速檢測裝置
    • 尿液檢查設備
    • 口腔液體檢測裝置
  • 耗材
    • 檢測套件
    • 樣品收集杯
    • 校準器控制
    • 其他
  • 化驗服務

5. 藥物濫用檢測市場（依樣本類型）

  • 市場概況
  • 尿
  • 口腔液體
  • 吐氣
  • 頭髮
  • 其他範例

6. 藥物濫用檢測市場（依最終用戶分類）

  • 市場概況
  • 職場/學校
  • 刑事司法系統與執法
  • 實驗室
  • 醫院

7. 藥物濫用檢測市場（按地區）

  • 市場概況
  • 北美洲
    • 主要市場趨勢和機遇
    • 美國藥物濫用檢測市場
    • 加拿大藥物濫用檢測市場
    • 墨西哥藥物濫用檢測市場
  • 歐洲
    • 主要市場趨勢和機遇
    • 法國藥物濫用檢測市場
    • 德國藥物濫用檢測市場
    • 義大利藥物濫用檢測市場
    • 西班牙藥物濫用檢測市場
    • 英國藥物濫用檢測市場
    • 其他歐洲國家藥物濫用檢測市場
  • 亞太地區
    • 主要市場趨勢和機遇
    • 中國的藥物濫用檢測市場
    • 日本藥物濫用檢測市場
    • 印度藥物濫用檢測市場
    • 韓國藥物濫用檢測市場
    • 澳洲藥物濫用檢測市場
    • 其他亞太地區藥物濫用檢測市場
  • 拉丁美洲、中東和非洲
    • 主要市場趨勢和機遇
    • 巴西藥物濫用檢測市場
    • 南非藥物濫用檢測市場
    • 沙烏地阿拉伯藥物濫用檢測市場
    • 其他拉丁美洲、中東和非洲藥物濫用檢測市場

第8章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 前 10 家公司的產品映射
  • 競爭儀錶板
  • 競爭熱圖
  • 主要企業的定位：2023年

第9章 公司簡介

  • The Dragerwerk AG And Co. KGaA
  • Abbott Laboratories
  • F. HOFFMANN-LA ROCHE AG
  • Bio Rad Laboratories, Inc.
  • Siemens AG
  • Thermo Fisher Scientific, Inc.
  • Laboratory Corporation Of America Holdings
  • Danaher Corporation
  • Quest Diagnostics Incorporated
  • Express Diagnostics International Inc.
簡介目錄
Product Code: A00035

The drug abuse testing market was valued at $5.0 million in 2023, and is projected to reach $8.8 million by 2033, growing at a CAGR of 6% from 2024 to 2033.

Drug Abuse Testing Market - IMG1

Drug abuse testing refers to the scientific process of identifying the presence of illicit drugs, prescription medications, or their metabolites in a person's system. This testing is conducted using biological specimens such as urine, blood, saliva, hair, or sweat to determine if an individual has used specific substances. Drug abuse testing is a critical tool in workplace safety, clinical diagnostics, legal investigations, and rehabilitation programs.

Alarming increase in prevalence of substance abuse disorders worldwide is a primary driver of the drug abuse testing market. According to a report by the United Nations Office on Drugs and Crime (UNODC), over 284 million people aged 15-64 used drugs at least once in 2022, underscoring the need for widespread testing. In addition, rise in awareness about the impact of substance abuse on public safety, such as impaired driving and drug-related crimes, has driven the demand for routine drug testing in law enforcement and traffic monitoring programs. Moreover, increase in global drug availability significantly contributes toward the market growth. For instance, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) reported in 2024 that Europe is experiencing unprecedented availability of various drugs, with cannabis being the most commonly used illicit drug, followed by cocaine. Furthermore, the availability of cost-effective and easy-to-use home drug testing kits has seen increased adoption among individuals and families, contributing to market expansion. However, sophisticated drug testing techniques, such as liquid chromatography-mass spectrometry, are expensive. This can limit their adoption, especially in resource-constrained healthcare settings. Fear of societal judgment and discrimination may deter individuals from undergoing drug testing voluntarily, further affecting the growth of testing programs. On the contrary, technological innovations, such as point-of-care testing devices, improved immunoassays, and mass spectrometry techniques, have made drug testing more accurate, faster, and accessible. Such developments are expected to offer remunerative opportunities for the expansion of the global market during the forecast period.

The drug abuse testing market is segmented into product & service, sample type, end user, and region. By product & service, the market is divided into analyzers, rapid testing devices, consumables and laboratory services. The analyzers segment is further segmented into immunoassay analyzers, chromatography analyzers and breath analyzers. The rapid testing devices is subdivided into urine testing devices and oral fluid testing devices. The consumables segment is further categorized into assay kits, sample collection cups, calibrators & controls, and others. Depending on sample type, the market is segregated into urine, oral fluid, breath, hair, and other samples. By end user, it is fragmented into workplaces & schools, criminal justice systems & law enforcement agencies, research laboratories, and hospitals. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By product & service, the analyzers segment dominated the market share in 2023.

On the basis of sample type, the urine segment exhibit the highest growth in 2023.

Depending on end user segment, the workplaces & schools segment garnered the largest share in 2023.

Region wise, North America held the largest market share in 2023, and is projected to grow at a high pace during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global drug abuse testing market include The Dragerwerk AG & Co. KGaA, Abbott Laboratories, F. HOFFMANN-LA ROCHE AG, Bio Rad Laboratories, Inc., Siemens AG, Thermo Fisher Scientific, Inc., Laboratory Corporation of America Holdings, Danaher Corporation, Quest Diagnostics Incorporated, and Express Diagnostics International Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Average Selling Price Analysis / Price Point Analysis
  • Criss-cross segment analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product And Service

  • Analyzers
    • Immunoassay analyzers
    • Chromatography analyzers
    • Breath analyzers
  • Rapid Testing Devices
    • Urine testing devices
    • Oral fluid testing devices
  • Consumables
    • Assay kits
    • Sample collection cups
    • Calibrators and controls
    • Others
  • Laboratory Services

By Sample Type

  • Urine
  • Oral Fluid
  • Breath
  • Hair
  • Other Samples

By End User

  • Workplaces and Schools
  • Criminal Justice Systems and Law Enforcement Agencies
  • Research laboratories
  • Hospitals

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • The Dragerwerk AG & Co. KGaA
    • Abbott Laboratories
    • F. HOFFMANN-LA ROCHE AG
    • Bio Rad Laboratories, Inc.
    • Siemens AG
    • Thermo Fisher Scientific, Inc.
    • Laboratory Corporation of America Holdings
    • Danaher Corporation
    • Quest Diagnostics Incorporated
    • Express Diagnostics International Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: DRUG ABUSE TESTING MARKET, BY PRODUCT AND SERVICE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Product And Service
  • 4.2. Analyzers
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
    • 4.2.5. Immunoassay analyzers
      • 4.2.5.1. Market Size and Forecast
    • 4.2.6. Chromatography analyzers
      • 4.2.6.1. Market Size and Forecast
    • 4.2.7. Breath analyzers
      • 4.2.7.1. Market Size and Forecast
  • 4.3. Rapid Testing Devices
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
    • 4.3.5. Urine testing devices
      • 4.3.5.1. Market Size and Forecast
    • 4.3.6. Oral fluid testing devices
      • 4.3.6.1. Market Size and Forecast
  • 4.4. Consumables
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country
    • 4.4.5. Assay kits
      • 4.4.5.1. Market Size and Forecast
    • 4.4.6. Sample collection cups
      • 4.4.6.1. Market Size and Forecast
    • 4.4.7. Calibrators and controls
      • 4.4.7.1. Market Size and Forecast
    • 4.4.8. Others
      • 4.4.8.1. Market Size and Forecast
  • 4.5. Laboratory Services
    • 4.5.1. Key Market Trends, Growth Factors and Opportunities
    • 4.5.2. Market Size and Forecast, By Region
    • 4.5.3. Market Share Analysis, By Country

CHAPTER 5: DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Sample Type
  • 5.2. Urine
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Oral Fluid
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Breath
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Hair
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country
  • 5.6. Other Samples
    • 5.6.1. Key Market Trends, Growth Factors and Opportunities
    • 5.6.2. Market Size and Forecast, By Region
    • 5.6.3. Market Share Analysis, By Country

CHAPTER 6: DRUG ABUSE TESTING MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Workplaces And Schools
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Criminal Justice Systems And Law Enforcement Agencies
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Research Laboratories
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country
  • 6.5. Hospitals
    • 6.5.1. Key Market Trends, Growth Factors and Opportunities
    • 6.5.2. Market Size and Forecast, By Region
    • 6.5.3. Market Share Analysis, By Country

CHAPTER 7: DRUG ABUSE TESTING MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Product And Service
    • 7.2.3. Market Size and Forecast, By Sample Type
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Drug Abuse Testing Market
      • 7.2.6.1. Market Size and Forecast, By Product And Service
      • 7.2.6.2. Market Size and Forecast, By Sample Type
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Drug Abuse Testing Market
      • 7.2.7.1. Market Size and Forecast, By Product And Service
      • 7.2.7.2. Market Size and Forecast, By Sample Type
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Drug Abuse Testing Market
      • 7.2.8.1. Market Size and Forecast, By Product And Service
      • 7.2.8.2. Market Size and Forecast, By Sample Type
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Product And Service
    • 7.3.3. Market Size and Forecast, By Sample Type
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Drug Abuse Testing Market
      • 7.3.6.1. Market Size and Forecast, By Product And Service
      • 7.3.6.2. Market Size and Forecast, By Sample Type
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Drug Abuse Testing Market
      • 7.3.7.1. Market Size and Forecast, By Product And Service
      • 7.3.7.2. Market Size and Forecast, By Sample Type
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Drug Abuse Testing Market
      • 7.3.8.1. Market Size and Forecast, By Product And Service
      • 7.3.8.2. Market Size and Forecast, By Sample Type
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Drug Abuse Testing Market
      • 7.3.9.1. Market Size and Forecast, By Product And Service
      • 7.3.9.2. Market Size and Forecast, By Sample Type
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Drug Abuse Testing Market
      • 7.3.10.1. Market Size and Forecast, By Product And Service
      • 7.3.10.2. Market Size and Forecast, By Sample Type
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest Of Europe Drug Abuse Testing Market
      • 7.3.11.1. Market Size and Forecast, By Product And Service
      • 7.3.11.2. Market Size and Forecast, By Sample Type
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Product And Service
    • 7.4.3. Market Size and Forecast, By Sample Type
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Drug Abuse Testing Market
      • 7.4.6.1. Market Size and Forecast, By Product And Service
      • 7.4.6.2. Market Size and Forecast, By Sample Type
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Drug Abuse Testing Market
      • 7.4.7.1. Market Size and Forecast, By Product And Service
      • 7.4.7.2. Market Size and Forecast, By Sample Type
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Drug Abuse Testing Market
      • 7.4.8.1. Market Size and Forecast, By Product And Service
      • 7.4.8.2. Market Size and Forecast, By Sample Type
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Drug Abuse Testing Market
      • 7.4.9.1. Market Size and Forecast, By Product And Service
      • 7.4.9.2. Market Size and Forecast, By Sample Type
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Drug Abuse Testing Market
      • 7.4.10.1. Market Size and Forecast, By Product And Service
      • 7.4.10.2. Market Size and Forecast, By Sample Type
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Drug Abuse Testing Market
      • 7.4.11.1. Market Size and Forecast, By Product And Service
      • 7.4.11.2. Market Size and Forecast, By Sample Type
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Product And Service
    • 7.5.3. Market Size and Forecast, By Sample Type
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Drug Abuse Testing Market
      • 7.5.6.1. Market Size and Forecast, By Product And Service
      • 7.5.6.2. Market Size and Forecast, By Sample Type
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Drug Abuse Testing Market
      • 7.5.7.1. Market Size and Forecast, By Product And Service
      • 7.5.7.2. Market Size and Forecast, By Sample Type
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Drug Abuse Testing Market
      • 7.5.8.1. Market Size and Forecast, By Product And Service
      • 7.5.8.2. Market Size and Forecast, By Sample Type
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Drug Abuse Testing Market
      • 7.5.9.1. Market Size and Forecast, By Product And Service
      • 7.5.9.2. Market Size and Forecast, By Sample Type
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping Of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. The Dragerwerk AG And Co. KGaA
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Abbott Laboratories
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. F. HOFFMANN-LA ROCHE AG
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Bio Rad Laboratories, Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Siemens AG
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Thermo Fisher Scientific, Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Laboratory Corporation Of America Holdings
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Danaher Corporation
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Quest Diagnostics Incorporated
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Express Diagnostics International Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments